MITF Expression Predicts Therapeutic Vulnerability to P300 Inhibition in Human Melanoma

Cancer Research - United States
doi 10.1158/0008-5472.can-18-2331
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

791 Up-Regulated SIRT7 Expression Contributed to Melanoma Growth by Promoting MITF Expression

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Targeting Lineage-Specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small Molecule Inhibitor of P300/CBP

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

MITF Upregulation Sensitizes Melanoma Cells to Antifolate Treatment

Cancer Discovery
Oncology
2013English

Pro-Survival Role of MITF in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2015English

1200 SIRT7 Epigenetically Regulates MITF to Promote Melanoma Growth

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Interactions of Melanoma Cells With Distal Keratinocytes Trigger Metastasis via Notch Signaling Inhibition of MITF

Molecular Cell
Cell BiologyMolecular Biology
2015English

PDK1 Mediates NOTCH1-mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition

Clinical Cancer Research
Cancer ResearchOncology
2019English

Trait Pessimism Predicts Vulnerability to Stress-Induced Anhedonia in Rats

2013English

Increased P16 and P53 Protein Expression Predicts Poor Prognosis in Mucosal Melanoma

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy